Galderma Group AG Company Description

Galderma Group AG operates as a dermatology company worldwide.

The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.

Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology.

The company was founded in 1981 and is headquartered in Zug, Switzerland.

Galderma Group AG

Country	Switzerland
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	6,545
CEO	Flemming Ornskov

Contact Details

Address: Zählerweg 10 Zug, 6300 Switzerland
Phone	41 58 455 85 92
Website	galderma.com

Stock Details

Ticker Symbol	GALD
Exchange	SIX Swiss Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CH1335392721
SIC Code	2834

Key Executives

Name	Position
Dr. Flemming Ornskov M.B.A., M.P.H.	Chief Executive Officer and Director
Thomas J. W. Dittrich	Chief Financial Officer
Adrian Murphy	Head of Global Operations
Emil Ivanov	Head of Strategy, Investor Relations and ESG
Christian Marcoux	Chief Communications Officer
Allison Pinkham	Chief Human Resources Officer